Enter content here

Enter content here

 
HomeDevelopment of recombinant p21 protein as a viable therapy for AIDSINVESTORS NEEDEDSCIENCE CONSULTANTNEWSExecutive SummaryBreast Cancer testp21 drug development

Enter content here

SCIENCE CONSULTANCY AVAILABLE
SCIENCE CONSULTANCY Availanle
·         PRECLINICAL STUDIES
  • Animal models of cardiovascular and renal diseases including heart and kidney transplantation models.
  • Studies with knockout and transgenic mice In vivo models of therapeutic drugs testing, side effects and half-life estimations
·         DEVELOPMENT OF DIAGNOSTIC ASSAYS
o    Development of cell based and molecular diagnostic assays
o    Identification of biomarkers        
  • MOLECULAR, IMMUNOLOGICAL AND CELL BIOLOGY BASED STUDIES
o    Quantitative gene expression (qPCR), Western blots and ELISA based experiments
o    Development of cell based and molecular diagnostic assays
o    Identification of biomarkers
·         IMMUNOTHERAPY OF CANCER
o    Generation of specific and non-specific effector cells
o    Purification of immune cell types
o    Identification of effector cells by flow cytometry
o    Radioactivity and flow cytometry based cytotoxicity assays
·         GRANT PROPOSAL AND REGULATORY DOCUMENTS WRITING
o    NIH and CDMRP (Congressionally directed medical research program) grant writing
o    Regulatory documents such as IND etc writing and submissions
o    SBIR/STTR grant writing
·         DRUG DEVELOPENT
o    Target identifications
o    Recombinant proteins and molecular antibody based drugs
o    Efficacy testing using in vitro and in vivo models
For more information please Contact us 
Ashwani Khanna PhD
443-896-4234

Enter supporting content here